• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.

     

    Find out more about it and REGISTER today!

  • 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Dementia Management Update"

    (session captured at the GAPNA 2018 Annual Conference)


    For September/October 2019 - Get Your Free CNE Now!

Radiation Therapy Linked to Dry Mouth in Elderly Patients with Head and Neck Cancers

Head and neck cancer may be treated by a combination of radiation therapy (RT) and chemotherapy, in addition to surgery.

A common side effect associated with RT for tumors arising in the head and neck region is xerostomia (dry mouth), a potentially serious post-treatment complication that can affect speech, chewing, and swallowing, and lead to gum infections, cavities, and loss of teeth.

New research shows elderly patients receiving RT either with or without chemotherapy had a higher cumulative incidence of developing xerostomia than those who had neither RT nor chemotherapy.

The risk of xerostomia was regardless of tumor stage at presentation, anatomic primary tumor site, and whether primary cancer treatment included surgery. It was higher in some subgroups of patients, namely in women with distant stage disease or in those with poorly differentiated localized tumors.

The risk of xerostomia was lower in patients 80 years or older with the anatomic tumor site at the salivary gland.

For details, see Liu, C-C. et al. (2011). Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer. American Journal of Therapeutics, 18, 206-215.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: